Norman Sharpless

9PUBLICATIONS
74CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Infant and child healthInformation systems for sustainable development and the public goodCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 27, 2024
miR-29 is an important driver of aging-related phenotypes.

Vijay Swahari, Ayumi Nakamura, Emilie Hollville

|Jun 02, 2023
The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer.

Joseph A Flores-Toro, Subhashini Jagu, Gregory T Armstrong

|Aug 24, 2021
Cancer Informatics for Cancer Centers: Scientific Drivers for Informatics, Data Science, and Care in Pediatric, Adolescent, and Young Adult Cancer.

Anthony R Kerlavage, Anne C Kirchhoff, Jaime M Guidry Auvil

|Apr 01, 2021
Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy.

Pataje G Prasanna, Deborah E Citrin, Jeffrey Hildesheim

|Jan 27, 2019
Cells exhibiting strong p16 promoter activation in vivo display features of senescence.

Jie-Yu Liu, George P Souroullas, Brian O Diekman

|May 11, 2018
Expression of p16INK4a is a biomarker of chondrocyte aging but does not cause osteoarthritis.

Brian O Diekman, Garrett A Sessions, John A Collins

Pageof 2

Frequent Collaborators

2 joint publications

Jinghui Zhang

2 joint publications

Warren A Kibbe

2 joint publications

Allison P Heath

2 joint publications

Samuel L Volchenboum